Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

November 18, 2024

October 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

October 25, 2024

Liraglutide Helps Shed Weight in Young Children With Obesity

News Daily News

Liraglutide Helps Shed Weight in Young Children With Obesity

September 13, 2024

TCTMD’s Top 10 Most Popular Stories for August 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

September 03, 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

August 31, 2024

Semaglutide May Ease Tobacco Use, Study Suggests

News Daily News

Semaglutide May Ease Tobacco Use, Study Suggests

August 01, 2024

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

July 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

July 01, 2024

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

Aspirin for Primary Prevention of CVD Remains Common in US

News Daily News

Aspirin for Primary Prevention of CVD Remains Common in US

June 24, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Statins Might Help in HFpEF—Even in the Absence of ASCVD

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

May 01, 2024

May 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

May 01, 2024

April 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

April 01, 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

Patients With CKD Remain Underrepresented in Trials of CV Meds

News Daily News

Patients With CKD Remain Underrepresented in Trials of CV Meds

March 08, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.